How comparable are patient outcomes in the "real-world" with populations studied in pivotal AML trials?

- Tiong, Ing Soo, Wall, Meaghan, Marlton, Paula, Johnston, Amanda, Enjeti, Anoop, Fong, Chun Yew, Cull, Gavin, Larsen, Stephen, Kennedy, Glen, Schwarer, Anthony, Kipp, David, Ramanathan, Sundra, Bajel, Ashish, Verner, Emma, Tiley, Campbell, Morris, E, Hahn, U, Moore, J, Taper, J, Purtill, D, Warburton, P, Stevenson, W, Murphy, N, Kalro, Akash, Tan, P, Beligaswatte, A, Mutsando, H, Hertzberg, M, Shortt, J, Szabo, F, Dunne, K, Wei, AH, Australasian Leukaemia and Lymphoma Group (ALLG),, Fleming, Shaun, Roberts, Andrew W., Thiagarajah, Nisha, Chua, Chong Chyn, Latimer, Maya, Yeung, David

Reporting bone marrow biopsies for myelodysplastic neoplasms and acute myeloid leukaemia incorporating WHO 5th edition and ICC 2022 classification systems: ALLG/RCPA joint committee consensus recommendations

- Ng, Ashley P., Adams, Rebecca, Tiong, Ing Soo, Seymour, Louise, Talaulikar, Dipti, Palfreyman, Emma, Enjeti, Anoop, Tate, Courtney

NETosis and thrombosis in vaccine-induced immune thrombotic thrombocytopenia

- Leung, Halina H. L., Perdomo, Jose, Ahmadi, Zohra, Zheng, Shiying S., Rashid, Fairooj N., Enjeti, Anoop, Ting, Stephen B., Chong, James J. H., Chong, Beng H.

A multi-center randomized controlled trial to reduce unmet needs, depression, and anxiety among hematological cancer patients and their support persons

- Stevenson, William, Bryant, Jamie, Watson, Rochelle, Sanson-Fisher, Rob, Oldmeadow, Christopher, Henskens, Frans, Brown, Christina, Ramanathan, Sundra, Tiley, Campbell, Enjeti, Anoop, Guest, Johanna, Tzelepis, Flora, Paul, Christine, D'Este, Catherine

Venetoclax combined with low-dose cytarabine for previously untreated patients with acute myeloid leukemia: Results from a phase Ib/II study

- Wei, Andrew H., Strickland, Stephen A., Chyla, Brenda, Popovic, Relja, Salem, Ahmed Hamed, Agarwal, Suresh, Xu, Tu, Fakouhi, Kaffa M., Humerickhouse, Rod, Hong, Wan-Jen, Hayslip, John, Roboz, Gail J., Hou, Jing-Zhou, Fiedler, Walter, Lin, Tara L., Walter, Roland B., Enjeti, Anoop, Tiong, Ing Soo, Savona, Michael, Lee, Sangmin

Activation of protein phosphatase 2A in FLT3+ acute myeloid leukemia cells enhances the cytotoxicity of FLT3 tyrosine kinase inhibitors

- Smith, Amanda M., Dun, Matthew D., Toop, Hamish, Lock, Richard B., Powell, Jason A., Thomas, Daniel, Guthridge, Mark A., Moore, Andrew, Ashman, Leonie K., Skelding, Kathryn A., Enjeti, Anoop, Verrills, Nicole M., Lee, Erwin M., Harrison, Celeste, Kahl, Richard, Flanagan, Hayley, Panicker, Nikita, Mashkani, Baratali, Don, Anthony S., Morris, Jonathan

To adhere or not to adhere: rates and reasons of medication adherence in hematological cancer patients

- Hall, Alix E., Paul, Chris, Bryant, Jamie, Lynagh, Marita C., Rowlings, Philip, Enjeti, Anoop, Small, Hannah

Variable plasma levels of Factor V Leiden correlate with circulating platelet microparticles in carriers of Factor V Leiden

- Lincz, Lisa F., Scorgie, Fiona E., Enjeti, Anoop, Seldon, Michael